News Releases
Printer Friendly Version Print | E-mail this page E-mail | E-mail Alerts Alerts | View contacts Contacts | Download Financial Tear Sheet Tear Sheet
Webcast ImageWebcast
Q3 2014 CryoLife, Inc. Earnings Conference Call (Replay)
10/28/14 at 10:00 a.m. ET
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
DateTitle
10/28/14CryoLife Third Quarter 2014 Revenues Increase 2 Percent to $37.1 Million
10/23/14CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2014
10/22/14Pat Mackin Joins CryoLife Board of Directors
10/14/14CryoLife Announces Release Date and Teleconference Call Details for 2014 Third Quarter Financial Results
08/07/14CryoLife Acquires Distribution Rights and Purchase Option for Genesee BioMedical's PhotoFix™ Bovine Pericardial Patch
08/05/14CryoLife to Present at 34th Annual Canaccord Genuity Growth Conference
07/30/14CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014
07/24/14CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million
07/15/14CryoLife Announces Release Date and Teleconference Call Details for 2014 Second Quarter Financial Results
07/10/14CryoLife Appoints Pat Mackin as President and Chief Executive Officer
05/22/14CryoLife Increases Quarterly Cash Dividend Nine Percent for the Second Quarter 2014
04/29/14CryoLife Posts Record First Quarter Revenues of $35.7 Million
04/29/14CryoLife Receives FDA 510(k) Clearance for PerClot® Topical Hemostatic Powder in the U.S.
04/15/14CryoLife Announces Release Date and Teleconference Call Details for 2014 First Quarter Financial Results
04/02/14CryoLife Receives FDA Approval to Begin Clinical Trials for PerClot® in the U.S.
03/27/14CryoLife Acquires Distribution Rights and Purchase Option for ProCol® Vascular Bioprosthesis for Hemodialysis Access
03/19/14CryoLife Continues To Support Customer Education With Third Central Venous Pathology Summit
02/20/14CryoLife Fourth Quarter 2013 Revenues Increased 8 Percent to a Record $35.5 Million
02/19/14CryoLife Announces Quarterly Cash Dividend for the First Quarter 2014
02/18/14CryoLife to Present at 2014 RBC Capital Markets' Global Healthcare Conference
02/18/14CryoLife Announces Expansion in Asia Pacific Markets
02/05/14CryoLife Announces Release Date and Teleconference Call Details for 2013 Fourth Quarter and Year End Financial Results
11/25/13CryoLife to Present at 25th Annual Piper Jaffray Healthcare Conference
11/21/13CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013
11/05/13CryoLife To Host Second Central Venous Pathology Summit in 2013
10/29/13CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million
10/24/13CryoLife Receives $15.4 Million Payment for its Shares of Medafor, Inc.
10/14/13CryoLife Announces Release Date and Teleconference Call Details for 2013 Third Quarter Financial Results
10/07/13CryoLife to Receive Approximately $15.1 Million from Acquisition of Medafor, Inc. by C. R. Bard, Inc.
09/16/13CryoLife To Host Aortic Valve and Root Training Session
08/21/13CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2013
07/31/13CryoLife Announces First European Implant Of HeRO Graft
07/25/13CryoLife Reports Record Second Quarter Revenues
07/11/13CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
07/10/13CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System
07/09/13CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager
06/19/13CryoLife Receives Conditional IDE Approval to Begin Clinical Trials for PerClot® in the U.S.
06/10/13CryoLife Receives CE Mark For HeRo® Graft
05/28/13CryoLife Increases Quarterly Cash Dividend 10 Percent for the Second Quarter 2013
04/30/13CryoLife 2013 First Quarter Revenues Grew 10 Percent to a Record $35.5 Million
04/09/13CryoLife Announces Release Date and Teleconference Call Details for 2013 First Quarter Financial Results
04/08/13CryoLife To Host Central Venous Pathology Summit
04/04/13CryoLife Receives FDA Clearance For Next Generation HeRO Device
02/14/13CryoLife Expands Stock Repurchase Program
02/14/13CryoLife 2012 Annual Revenues Grew to a Record $131.7 Million
02/13/13CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
01/31/13CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
12/05/12CryoLife Receives Expanded Indication for BioFoam in Europe
11/20/12CryoLife to Present at 24th Annual Piper Jaffray Health Care Conference
11/19/12CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2012
11/06/12CryoLife to Participate in Lazard Capital Markets 9th Annual Healthcare Conference
10/30/12CryoLife Reports 13% Revenue Growth for Third Quarter 2012
10/11/12CryoLife Announces Release Date and Teleconference Call Details for 2012 Third Quarter Financial Results
08/21/12CryoLife Announces Initiation of Quarterly Cash Dividend
07/31/12CryoLife Reports 13% Revenue Growth for Second Quarter 2012
07/11/12CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
06/14/12CryoLife Announces Settlement of Patent Litigation with CardioFocus
06/14/12CryoLife Announces Settlement of Medafor Lawsuit
05/23/12CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
05/21/12Jon Salveson Joins CryoLife Board of Directors
05/16/12CryoLife Completes Acquisition of Hemosphere
05/15/12CryoLife to Acquire Hemosphere
04/26/12CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
04/12/12CryoLife Announces Release Date and Teleconference Call Details for 2012 First Quarter Financial Results
02/16/12CryoLife Reports Record Quarterly Revenues in Fourth Quarter of 2011
02/02/12CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
01/04/12CryoLife Enhances Management Team with Promotions
11/29/11CryoLife to Present at 6th Annual Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference
11/21/11CryoLife to Present at 23rd Annual Piper Jaffray Health Care Conference
11/03/11CryoLife to Present at Upcoming Investor Conferences in New York
11/01/11CryoLife Expands Stock Repurchase Program
10/31/11CryoLife Closes $20 Million Credit Facility with GE Capital, Healthcare Financial Services
10/27/11CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
10/24/11CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
10/17/11CryoLife Announces Release Date and Teleconference Call Details for 2011 Third Quarter Financial Results
10/13/11CryoLife Provides Update on ValveXchange®, Inc. Investment
07/28/11CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
07/20/11CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results
07/07/11CryoLife Makes Equity Investment in ValveXchange® Inc.
05/17/11CryoLife Announces Completion of Acquisition of Cardiogenesis
05/06/11CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
05/03/11CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
04/28/11CryoLife Posts Record Quarterly Revenues of $30.2 Million
04/25/11CryoLife Launches BioGlue(R) Surgical Adhesive in Japan
04/18/11CryoLife Announces Release Date and Teleconference Call Details for 2011 First Quarter Financial Results
04/18/11CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation
04/15/11CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
04/05/11CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
04/04/11CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot(R) in the U.S.
03/29/11CryoLife Signs Definitive Agreement to Acquire Cardiogenesis
02/17/11CryoLife Posts Record Annual Revenues of $116.6 Million
02/01/11CryoLife Announces Release Date and Teleconference Call Details for 2010 Fourth Quarter and Year End Financial Results
11/09/10CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11/04/10CryoLife Posts Record Third Quarter Revenues of $28.4 Million
10/25/10CryoLife Begins Distribution of Blood-Clotting Agent PerClot(R) in Europe
10/14/10CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
10/12/10The Ross Summit 2010 to Focus on New Survival Data, Technique Refinement and Availability of the Procedure
10/07/10CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
10/04/10David P. Lang Appointed Vice President of CryoLife International, Inc.
09/28/10CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
09/15/10CryoLife to Present at UBS Global Life Sciences Conference
08/09/10CryoLife Receives FDA 510(k) Clearance for CryoPatch(R) SG Pulmonary Human Cardiac Patch Shelf-life Extension
07/29/10CryoLife Posts Record Second Quarter Revenues and Operating Income
07/08/10CryoLife Announces Release Date and Teleconference Call Details for 2010 Second Quarter Financial Results
06/30/10CryoLife Announces Medafor Resuming Shipments of HemoStase(R)
06/16/10CryoLife to Present at Sidoti's 2010 Semi Annual New York Micro-Cap Conference
06/08/10CryoLife Receives FDA 510(k) Clearance for CryoValve(R) SG Pulmonary Heart Valve Shelf-life Extension
06/07/10CryoLife Strengthens BioGlue(R) Surgical Adhesive Portfolio with Patent Purchase
06/01/10CryoLife Board of Directors Authorizes Purchase of its Common Stock
05/27/10CryoLife to Present at Jefferies 2010 Global Life Sciences Conference
05/25/10CryoLife Sends Letter to Medafor, Inc. Shareholders
04/28/10CryoLife Grows First Quarter Revenues by 11 Percent to a Record $29.7 Million
04/15/10CryoLife Announces Release Date and Teleconference Call Details for 2010 First Quarter Financial Results
04/13/10Medafor Abandons Efforts to Deny Shareholder Status to CryoLife CEO
03/30/10CryoLife Files for Preliminary Injunction Against Medafor
03/24/10CryoLife Withdraws Its Proposal to Acquire Medafor
03/19/10CryoLife Comments on Status of Medafor Distribution Agreement
03/18/10CryoLife Sends Letter to Medafor, Inc. Board of Directors
03/11/10CryoLife Sends Letter to Medafor, Inc. Shareholders
02/23/10CryoLife Sends Letter to Medafor, Inc. Shareholders
02/18/10CryoLife Grows Fourth Quarter Revenues by 12 Percent to a Record $28.6 Million
02/17/10CryoLife Sends Letter to Medafor, Inc. Board of Directors
02/09/10CryoLife Sends Letter to Medafor, Inc. Shareholders
02/08/10CryoLife Sends Letter to Medafor, Inc. Board of Directors
02/02/10CryoLife Increases Stake in Medafor, Inc. to Approximately 11 Percent
02/01/10CryoLife Announces Release Date and Teleconference Call Details for 2009 Fourth Quarter and Year End Financial Results
01/21/10CryoLife Sends Letter to Medafor, Inc. Shareholders
01/13/10CryoLife Becomes Largest Shareowner of Medafor, Inc. and Proposes Combination Between the Two Companies
12/01/09CryoLife Provides Initial 2010 Financial Guidance
11/23/09CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
11/11/09CryoLife to Present at Upcoming Investor Conferences in New York
10/29/09CryoLife Reports Record Quarterly Revenues of $28.2 Million
10/27/09CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
10/13/09CryoLife Announces Release Date and Teleconference Call Details for 2009 Third Quarter Financial Results
10/06/09CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
09/21/09Leading Cardiovascular Surgeons Gather from Around the World to Share Ross Procedure Survival Data, Techniques at 2nd Annual Summit
09/14/09CryoLife to Present at UBS Global Life Sciences Conference
09/10/09CryoLife Announces First Clinical Use of BioFoam(R)
09/03/09CryoLife's Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World
08/18/09CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material
08/12/09CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Cardiac Patch Material
08/04/09CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
07/30/09CryoLife Reports Record Quarterly Revenues of $28.2 Million
07/13/09CryoLife Announces Release Date and Teleconference Call Details for 2009 Second Quarter Financial Results
06/29/09BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
04/30/09CryoLife Reports Record First Quarter Revenues of $26.7 Million
04/15/09CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results
04/06/09Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology
03/19/09CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum
02/19/09CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
02/17/09FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve
02/05/09CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results
01/21/09CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
11/24/08CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference
10/30/08CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
10/16/08CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2008 Financial Results
10/07/08CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
09/22/08CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc.
09/17/08CryoLife to Present at UBS Global Life Sciences Conference
09/11/08CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
08/04/08CryoLife Announces Management Promotions
07/31/08CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
07/15/08CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2008 Financial Results
06/30/08Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
06/10/08CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
05/27/08CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference
05/12/08CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
05/01/08Harvey Morgan Joins CryoLife Board of Directors
04/30/08CryoLife's Earnings Per Share Increases 150 Percent to $0.10 in First Quarter of 2008 from $0.04 in First Quarter of 2007
04/24/08CryoLife Conducts Surgeons Cardiac Allograft Symposium
04/17/08CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
04/14/08CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results
04/08/08William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
03/31/08CryoLife Closes on $15 Million Credit Facility with GE Healthcare Financial Services
03/24/08CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
02/21/08CryoLife Reports Net Income of $0.26 Per Share in 2007 Compared to a Net Loss of ($0.02) Per Share in 2006
02/13/08CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
02/07/08CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
01/31/08CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
01/11/08CryoLife Responds to Inaccurate Assertions from Plaintiff's Attorney
01/10/08CryoLife Announces Record Preservation Services and Product Revenues for 2007
01/08/08CryoLife Announces Worldwide License Agreement With Trophic Solutions, LLC for an Organ Transport Solution That Could Extend the Storage Time for Kidneys From 3 to 6 Days
01/02/08CryoLife to Present at OneMedPlace Finance Forum
11/20/07CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
11/01/07CryoLife Reports Third Consecutive Profitable Quarter
10/30/07CryoLife Announces Additions to Management Team
10/18/07CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
10/11/07CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
09/17/07CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
09/05/07CryoLife to Present at Bear Stearns Healthcare and First Albany Capital's Regenerative Technologies Conferences in New York
09/04/07CryoLife Names Philip Theodore as Vice President, General Counsel
07/31/07CryoLife Reports Second Quarter and First Half 2007 Financial Results
07/11/07CryoLife Announces Preliminary First Half 2007 Revenues Increase 18% to Approximately $47.2 Million
07/10/07CryoLife Establishes Direct Sales Force in Germany
06/26/07BioForm Medical Enrolls First Patient in Clinical Trial of CryoLife's BioGlue(R) Surgical Adhesive for Use in Cosmetic and Plastic Surgery
06/14/07CryoLife Awarded U. S. Patent for BioFoam(R)
06/04/07CryoLife Exercises Right to Convert Preferred Stock into Common Stock
05/01/07CryoLife's First Quarter 2007 Revenues up 26 Percent
04/30/07CryoLife's BioDisc(TM) Nucleus Pulposus Replacement to be Featured at Two Medical Conferences in Berlin
04/10/07CryoLife Announces Preliminary First Quarter 2007 Revenues of Approximately $24.4 Million
03/13/07CryoLife Declares a Dividend of Approximately $0.75 Per Share on Its Convertible Preferred Stock
02/20/07CryoLife Returns to Profitability in 2006
02/08/07CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2006 Financial Results
01/17/07CryoLife Signs Agreement With MAST Biosurgery, Inc. to Distribute CardioWrap(TM) in U. S.
01/11/07CryoLife Announces Preliminary Fourth Quarter 2006 Revenues of Approximately $21 Million
01/10/07CryoLife Announces Agreement with Cleveland Clinic to Develop Innovative Heart Valve for High Risk Patients
12/20/06CryoLife Provides Additional Comments on Exchange and Service Agreement with Regeneration Technologies
12/19/06Cryolife and Regeneration Technologies Enter Into Exchange and Service Agreement
12/13/06CryoLife Receives European and Canadian Approval to Market New Rigid Applicator Tip for BioGlue(R) Surgical Adhesive
12/11/06CryoLife to Present at MedTech Insight's In Spine & Orthopedics Conference in Las Vegas
12/11/06CryoLife Receives FDA 510(k) Clearance for ProPatch(TM) Soft Tissue Repair Matrix
12/05/06CryoLife Declares a Dividend of Approximately $0.75 Per Share on Its Convertible Preferred Stock
11/29/06CryoLife To Present at 18th Annual Piper Jaffray Health Care Conference in New York
11/02/06CryoLife Identifies Key Growth Strategies as Result of Strategic Review
11/02/06CryoLife Reports Profitable Third Quarter 2006
10/30/06CryoLife Announces Agreement With BioForm Medical to Develop and Market BioGlue(R) for Use In Cosmetic and Plastic Surgery
10/19/06CryoLife Conducts Cardiac Allograft Symposium
10/18/06Signed Defense Bill Provides 2007 Funding for Protein Hydrogel Development
10/12/06CryoLife's Preliminary 2006 Third Quarter Revenues Increased 22% Compared to 2005, Company Provides Conference Call Information
10/02/06CryoLife to Receive $2.25 Million to Settle Dispute
09/07/06CryoLife Declares a Dividend of Approximately $0.75 Per Share on Its Convertible Preferred Stock
08/03/06CryoLife Reports Profitable Second Quarter
07/19/06CryoLife Completes Enrollment Of BioDisc(TM) Study
07/11/06CryoLife Announces Preliminary Second Quarter 2006 Revenues of $20.8 Million
06/19/06CryoLife Receives Tissue from 85,000th Donor
06/07/06CryoLife Declares a Dividend of Approximately $0.75 Per Share on Its Convertible Preferred Stock
05/09/06CryoLife's BioDisc(TM) Nucleus Pulposus Replacement To be Featured at Two Medical Conferences in Montreal
05/03/06CryoLife Reports First Quarter 2006 Financial Results
04/26/06CryoLife Announces Interim Results of European BioDisc(TM) Spinal Disc Repair System Study at Britspine
04/20/06CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2006 Financial Results
04/13/06CryoLife Announces Preliminary First Quarter 2006 Revenues
04/06/06CryoLife to Conduct Annual Cardiac Surgery Fellows Program
03/13/06CryoLife Declares a Dividend of Approximately $0.75 on Its Convertible Preferred Stock
02/22/06CryoLife Reports Fourth Quarter and Full Year 2005 Financial Results
02/13/06CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2005 Financial Results
02/09/06CryoLife Receives FDA Approval of New Spreader Tips for BioGlue(R) Syringe Applicators
01/24/06Signed Defense Bill Provides Continued Funding Stream for BioFoam(TM) Development
01/18/06CryoLife Retains Piper Jaffray & Co. to Assist in the Review of Potential Strategies
01/12/06CryoLife Receives FDA Approval of New, Larger Delivery System for BioGlue(R) Surgical Adhesive
01/10/06CryoLife Announces Preliminary 2005 Revenues
12/28/05CryoLife Amends Its Bylaws
12/28/05CryoLife Names Former FDA Official James S. Benson to its Board of Directors
12/12/05CryoLife Declares a Dividend of Approximately $0.75 on its Convertible Preferred Stock
11/03/05CryoLife Reports Third Quarter 2005 Financial Results
11/02/05CryoLife Updates Status of BioDisc(TM) Spinal Disc Repair System at MedTech Insight's In Spine & Orthopedics Conference
10/20/05CryoLife to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference in New York
10/19/05CryoLife Announces Release Date and Teleconference Call Details for the Third Quarter 2005 Financial Results
10/06/05CryoLife Conducts Cardiac Reconstruction Surgery Symposium
09/28/05Positive Results of BioGlue(R) in Treating Alveolar Air Leaks Presented at International Medical Conference
09/12/05CryoLife Declares a Dividend of Approximately $0.75 on its Convertible Preferred Stock
09/06/05CryoLife Announces First Human Implants of BioDisc(TM) Spinal Disc Repair System
08/11/05CryoLife to Label High-Dose Irradiated Orthopaedic Tissue Sterile
08/04/05Cryolife's Second Quarter 2005 Revenues Increased 12% Over Second Quarter 2004
07/28/05CryoLife Announces Release Date and Teleconference Call Details for the Second Quarter 2005 Financial Results
07/28/05CryoLife Announces Agreements in Principle to Settle Shareholder Class Action and Shareholder Derivative Action Lawsuits
07/07/05CryoLife Appoints Gerald B. Seery Vice President of International Operations
06/20/05CryoLife and The Magdi Yacoub Institute Sign Research Collaboration to Improve Xenografts for Human Transplantation
06/02/05CryoLife Declares a Dividend of Approximately $0.87 on Its Convertible Preferred Stock
05/26/05Positive Results of CryoLife's SynerGraft Model #100 Arteriovenous (AV) Access Device Presented at International Medical Congress
05/10/05CryoLife Announces Implant of its Cryopreserved Orthopaedic Tissues Treated With the Clearant Process
05/06/05CryoLife Conducts Annual Cardiac Surgery Fellows Program
05/05/05CryoLife First Quarter Revenues Increase 17% Over First Quarter 2004
04/26/05CryoLife Announces Release Date and Teleconference Call Details for the First Quarter 2005 Financial Results
04/14/05CryoLife Appoints David M. Fronk Vice President, Regulatory Affairs and Quality Assurance
03/15/05CryoLife Announces Pricing of 6% Convertible Preferred Stock
02/23/05CryoLife Announces First Implant of Cryopreserved Osteoarticular Allograft
02/22/05CryoLife Reports Fourth Quarter and Full Year 2004 Financial Results
02/15/05CryoLife Announces Release Date and Teleconference Call Details for the 4th Quarter and Year End 2004 Financial Results
02/10/05CryoLife Receives American Association of Tissue Banks (AATB) Accreditation
02/09/05CryoLife, Inc. Receives Line of Credit for up to $15 Million; Strengthens the Company's Financial Position
02/01/05CryoLife Receives American Association of Tissue Banks (AATB) Accreditation
01/20/05CryoLife Human Heart Valve Clinical Experience Report Demonstrates Positive Long-Term Outcomes
01/10/05CryoLife and Endologix Sign Development Agreement for BioFoam
12/17/04CryoLife Files Shelf Registration Statement
12/14/04Albert E. Heacox, Ph.D. Assumes Senior Vice President of Research and Development Position for CryoLife, Inc.
11/11/04CryoLife Presents Positive Preclinical Results for Its BioDisc(TM) Spinal Disc Nucleus Repair System
11/04/04CryoLife Reports Third Quarter 2004 Financial Results
11/03/04Updated Information on CryoLife Promotion of D. Ashley Lee to Executive Vice President, Chief Operating Officer and Chief Financial Officer
11/03/04CryoLife Promotes D. Ashley Lee to Executive Vice President
10/29/04CryoLife Reports Settlement of Cases
10/18/04CryoLife Announces Release Date and Teleconference Call Details for the Third Quarter 2004 Financial Results
09/16/04Positive Results of Cryolife's Synergraft(R) Arteriovenous Access Device In Dialysis Patients Presented At A European Medical Congress
08/05/04CryoLife Reports Second Quarter 2004 Financial Results
07/29/04Defense Bill Passed by the U.S. Senate and U.S. House of Representatives Provides Funding for BioFoam(TM) Development
07/14/04CryoLife Announces Release Date and Teleconference Call Details for the Second Quarter 2004 Financial Results
07/01/04Measure for Funding the Development of BioFoam(TM) was Passed by the U.S. House of Representatives
05/19/04CryoLife Receives CE Mark Approval for Distribution in the European Union of a New Delivery System for BioGlue(R) Surgical Adhesive
05/17/04CryoLife Receives FDA Approval of New Delivery System for BioGlue(R) Surgical Adhesive
05/13/04Cryolife Files Form 10-Q For First Quarter 2004
05/10/04CryoLife First Quarter 2004 Revenues Up 18% Over Fourth Quarter 2003
04/26/04CryoLife Announces Release Date and Teleconference Call Details for the First Quarter 2004 Financial Results
04/22/04BioGlue(R) Surgical Adhesive is Safe and Effective in Range of Cardiac Surgical Procedures
02/26/04CryoLife Reports Fourth Quarter and Full Year 2003 Financial Results
02/10/04CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter & Year Ended December 31, 2003 Financial Results
02/06/04CryoLife Provides Update on 510(K) Premarket Notification for CryoValve SG Decellularized Human Heart Valves
01/27/04CryoLife To Present at U.S. Bancorp Piper Jaffray Health Care Conference in New York
01/26/04CryoLife Announces $20 Million Private Placement of Common Stock
01/12/04Cryolife Registry Demonstrates Positive Adult and Pediatric Long-Term Outcomes Following Heart Valve Implantation
01/07/04CryoLife Announces Revenues for 2003, Expects Increase in 2004
12/15/03CryoLife Licenses Novel Technology for Microorganism Inactivation of Orthopaedic Tissue
12/08/03Thomas Ackerman and Dan Bevevino Join Cryolife, Inc. Board of Directors
11/04/03CryoLife(R) Reports Third Quarter 2003 Financial Results
11/03/03CryoLife(R) Resolves Insurance Coverage Dispute on a $10 Million Policy
10/22/03CryoLife Announces Release Date and Teleconference Call Details for the Third Quarter 2003 Financial Results
10/20/03CryoLife to Respond to Recent FDA Inspection Observation
09/09/03CryoLife(R) Announces Results of Aurazyme(R)'S Pre-Clinical Animal Trials of AZ-CINN 310 to Treat Breast Cancer
08/20/03CryoLife(R) Names Gregory Ray, MD Associate Medical Director
08/19/03CryoLife(R) Names Thomas J. Lynch, J.D., Ph.D., Vice President, Regulatory Affairs and Quality Assurance
08/05/03CryoLife(R) Reports Second Quarter 2003 Financial Results
07/22/03CryoLife Announces Release Date And Teleconference Call Details For The Second Quarter 2003 Financial Results
07/11/03CryoLife(R) Comments on Product Liability Cases and Related Insurance Coverage
05/01/03CryoLife Reports First Quarter 2003 Financial Results
04/22/03CryoLife Announces Release Date and Teleconference Call Details for the First Quarter 2003 Financial Results
04/09/03CryoLife Appoints New Corporate Communications Executive
03/31/03CryoLife Settles Lawsuit
03/24/03CryoLife to Present at Banc of America Securities Health Care Conference In Las Vegas
03/19/03FDA Renews Interim Agreement With Cryolife
03/12/03CryoLife(R), Inc. Pharmaceuticals Subsidiary Awarded Research Grant To Advance Clot-Dissolving Technology
02/26/03CryoLife, Inc. Management Reviewed 2002 Operating Events In Teleconference Call
02/25/03CryoLife Reports Fourth Quarter And Full-Year Results; Resumes Processing of Orthopaedic Tissues
02/18/03CryoLife Reinspected By U.S. Food And Drug Administration
02/14/03CryoLife Announces Release Date and Teleconference Call Details for The Fourth Quarter and Year Ended December 31, 2002
02/13/03CryoLife's BioGlue(R) Surgical Adhesive Approved for Soft Tissue Repair in Canada
02/05/03CryoLife(R) Signs Exclusive Distribution Agreement With curasan AG
02/04/03CryoLife's BioGlue Shown Effective in Pituitary Tumor Surgery
02/03/03CryoLife's BioGlue(R) Surgical Adhesive Shown To Reduce Bleeding In Ventricular Assist Device Surgery
01/30/03CryoLife Presents at U.S. Bancorp Piper Jaffray Conference in New York
01/28/03CryoLife To Present At U.S. Bancorp Piper Jaffray Health Care Conference In New York
01/13/03FDA Renews Interim Agreement With CryoLife; Company Continues Tissue Processing and Distribution Under Agreement
01/06/03CryoLife Announces Clarification of Interim Agreement With FDA
12/23/02CryoLife, Inc. Continues Cooperation with the FDA
11/08/02FDA Renews Interim Agreement With CryoLife
10/30/02CryoLife, Inc. Management Reviewed Third Quarter Operating Events In Teleconference Call
10/29/02CryoLife Reports Third Quarter and Nine-Month Results
10/25/02CryoLife Announces Release Date and Teleconference Call Details for the Third Quarter and Nine Months Ended September 30, 2002
10/10/02CryoLife's BioGlue(R) Helps to Seal Vessels and Reduce Bleeding in Vascular Surgery Procedures
10/08/02CryoLife Submits Corrective Action Plan to FDA
09/06/02CryoLife Reaches Agreement With FDA to Resume Limited Tissue Processing And Distribution
09/04/02CryoLife Announces Filing and Certification of 10-Q; Revises Previously Announced 2002 Second Quarter Results Due to FDA Order
08/19/02CryoLife Comments on Filing of Form 10-Q
08/19/02CryoLife Provides Further Detail Regarding SEC Investigation
08/19/02CryoLife Announces SEC Investigation
08/16/02Doctors Across the Nation Support CryoLife, Inc.; Physicians Voice Support in Media
08/15/02CryoLife, Inc. Details Responses To The FDA; CryoLife Continues to Submit Validation Data to FDA
08/15/02CryoLife, Inc. Intends To File 10-Q on Monday, August 19, 2002
08/14/02CryoLife Announces Additional Information During Conference Call
08/14/02CryoLife, Inc. Receives FDA Order
08/14/02CryoLife, Inc. Announces Conference Call at 4:00 PM Today
08/13/02CryoLife, Inc. Secures $10 Million Line of Credit; Credit Line Strengthens the Company's Financial Position
08/07/02CryoLife, Inc. Announces Technology Acquisition And Settlement of Litigation With Colorado State University
07/30/02CryoLife Announces That It Believes Class Action Lawsuits Are Meritless; Company Intends to Vigorously Defend Suits and Retains King & Spalding
07/24/02CryoLife, Inc. Management Reviews Operating Events In Teleconference Call Following Release of Second Quarter and First Half of 2002 Revenues and Earnings Results
07/23/02CryoLife, Inc. Board of Directors Authorizes Purchase of Its Common Stock
07/23/02CryoLife, Inc. Reports Record Revenues And Record Net Income For The First Half Of 2002
07/11/02CryoLife Announces Release Date and Teleconference Call Details For the Second Quarter 2002 Revenues and Earnings Results
07/05/02CryoLife, Inc. Announces Corrections to Its June 24, 2002 Press Release
06/24/02CryoLife, Inc. Announces Conference Call at 8:30 AM Tomorrow To Discuss FDA Letter
06/24/02CryoLife, Inc. Updates Actions of FDA
06/12/02CryoLife, Inc., Pharmaceuticals Subsidiary Awarded Research Grant To Advance Cancer Treatment Drug Delivery System
05/07/02CryoLife, Inc. Appoints New Accounting Firm
04/23/02CryoLife, Inc. Management Reviewed Operating Events in Teleconference Call Following Release of Record First Quarter Revenues and Earnings Results
04/23/02CryoLife, Inc. Reports Record Revenues and Record Earnings For the First Quarter of 2002
04/16/02CryoLife Announces Release Date and Teleconference Call Details for the First Quarter 2002 Revenues and Earnings Results
04/09/02CryoLife(R), Inc. Terminates Its Accounting Services With Arthur Andersen, LLP
03/29/02CryoLife, Inc. Corrects Previously Announced 2001 Earnings to Record Non-Cash Non-Operating Charges Related to Marketable Securities
03/15/02CryoLife, Inc. Replies to Recent Articles and Announces Conference Call At 12:45 pm Today
03/12/02CryoLife(R), Inc. Selected as Recipient of Frost & Sullivan Market Penetration Award for Its BioGlue(R) Surgical Adhesive
03/11/02CryoLife, Inc. Appoints Gerald B. Seery President, CryoLife Europa, Ltd.
02/12/02CryoLife(R), Inc.'S BioGlue Surgical Adhesive Approved for General Surgery Procedures in Europe
01/29/02CryoLife, Inc. Management Reviewed Operating Events In Teleconference Call Following Release of Fourth Quarter and Year End 2001 Revenues and Earnings Results
01/29/02CryoLife(R), Inc., Signs Distribution and Allocation Agreements With AlloSource(R)
01/29/02CryoLife, Inc. Reports Record Revenues and Record Earnings For Both The Fourth Quarter and The Year 2001
01/17/02CryoLife Announces Release Date and Teleconference Call Details for the Fiscal Year 2001 Revenues and Earnings Results
01/03/02CryoLife, Inc. to Post Record Revenues for the Year 2001; FDA Approved BioGlue Shipped in December 2001
12/20/01CryoLife, Inc. Stock to be Listed on the Chicago Board Options Exchange
12/14/01CryoLife, Inc. Reports CDC Provides Additional Information Relating To Rare Bacterial Infection Case
12/07/01Cryolife, Inc. Cooperates With Health Agencies on Rare Bacterial Infection
12/04/01CryoLife, Inc. Reports FDA Approval for BioGlue(R) Surgical Adhesive Use in Vascular Repair for Hemostasis
11/29/01CryoLife, Inc. Hosts Industry Analysts at its Newly Expanded Headquarters, Laboratory, and Manufacturing Facilities
11/19/01CryoLife, Inc. Announces Baylor College of Medicine Animal Study Supports Use of BioGlue(R) in Phrenic Nerve Environment
10/31/01Cryolife, Inc. Presents Research Results on Injectable Spinal Disc Device At Industry Forum
10/17/01CryoLife, Inc. Management Reviews Operating Events in Teleconference Call Following Release of 3rd Quarter and Nine Month Revenues and Earnings Results
10/16/01CryoLife, Inc. Reports Record Revenues and Record Net Income For Both Third Quarter and Nine Months Of 2001
10/15/01CryoLife, Inc. Selected for the FORBES Magazine 200 Best Small Companies in America
10/10/01CryoLife, Inc. Reports Record Revenues for Third Quarter 2001 At Industry Conference
10/02/01CryoLife Announces Release Date and Teleconference Call Details For Third Quarter 2001 Revenues and Earnings Results
09/25/01CryoLife Inc. Files Trademark Infringement Suit Against Sulzer Carbomedics, Inc.
09/19/01CryoLife's BioGlue(R) Surgical Adhesive Featured at Military Combat Care Conference
09/17/01FDA Panel Recommends Approval of CryoLife's BioGlue(R) Surgical Adhesive for Use in Vascular and Cardiac Repair
09/05/01CryoLife's Pharmaceutical Subsidiary to Present Progress Report on Development of Cancer Treatment Drug Delivery System at International Conference
08/23/01CryoLife, Inc. Receives CE Mark Approval For Synergraft(R) Tissue-Engineered Vascular Graft For Dialysis Access And Peripheral Vascular Reconstruction
08/16/01CryoLife, Inc. Files Premarket Approval Application (PMA) With FDA for CryoLife-O'Brien(R) Aortic Heart Valve
07/17/01CryoLife, Inc. Management Reviews Operating Events in Teleconference Call Following Release of 2nd Quarter and First Half Of 2001 Revenues and Earnings Results
07/17/01CryoLife, Inc. Reports Record Revenues and Record Net Income for Both Second Quarter and First Half of 2001
07/09/01CryoLife Announces Release Date and Teleconference Call Details for 2nd Quarter 2001 Revenues and Earnings Results
06/21/01Results of Thirteen Year Follow-Up Study on Aortic Heart Valve Replacement Therapy Reported at Thoracic Surgery Conference
06/18/01CryoLife, Inc. Tissue-Engineered Replacement Heart Valve Featured at International Conference
06/15/01CryoLife, Inc.'s SynerGraft Heart Valve Technology Presented at International Heart Valve Symposium
06/12/01CryoLife, Inc. Advances Its SynerGraft Tissue-Engineering Technology For Transpecies Applications
05/30/01CryoLife, Inc. Advances Development Of An Injectable Spinal Disc Replacement Device
05/29/01CryoLife, Inc. Confirms Dispute
05/08/01CryoLife, Inc. BioGlue Surgical Adhesive Study Results Presented At American Association for Thoracic Surgery Meeting
05/07/01CryoLife, Inc. Tissue-Engineering Heart Valve Technology Featured At Cardiovascular Surgical Conference
04/18/01CryoLife, Inc. Receives 'CE Mark' Approval for Distribution of Model 700 Synergraft Tissue-Engineered Pulmonary Heart Valves in Europe
04/17/01CryoLife, Inc. Reports 54% Increase in Net Income During the First Quarter Of 2001 as Compared to the First Quarter of 2000
04/10/01CryoLife Announces Release Date for First Quarter Revenues and Earnings And Shareholder Access to Teleconference Call Following Release of First Quarter Results
03/13/01CryoLife, Inc. Announces Formation of a New Wholly Owned Pharmaceutical Subsidiary and Corporate Marketing Management Changes
03/06/01CryoLife, Inc. Reports Results Of Eight Year Follow-Up Study On Cryopreserved Meniscus Use In Knee Reconstructive Surgery
02/22/01CryoLife, Inc. Announces First Implant Of Its Tissue-Engineered Synergraft Heart Valve in Norway
02/07/01CryoLife, Inc Receives Approval to Market BioGlue Surgical Adhesive in Australia
02/06/01CryoLife, Inc. Enters A Long-Term Agreement With Mid-South Tissue Bank
02/01/01CryoLife, Inc. Files Premarket Approval Application With FDA for Bioglue Surgical Adhesive for Vascular and Cardiac Repair
01/31/01CryoLife, Inc. Reports Record Revenues and Record Earnings for the Year 2000
01/24/01CryoLife Announces Fiscal Year 2000 Revenues and Earnings, Release Date and Teleconference Call Details
01/17/01CryoLife, Inc. Announces New Tissue-Engineered Vascular Graft for Dialysis Patients
11/28/00CryoLife, Inc. Files Investigational Device Exemption With FDA for BioGlue Surgical Adhesive for Use in Pulmonary Repair
11/27/00CryoLife, Inc. Declares A 3-For-2 Stock Split
11/15/00CryoLife, Inc. Awarded Grant From The National Institutes Of Health (NIH) for Its SynerGraft Tissue Technology
11/07/00CryoLife, Inc. Added to Standard & Poor's SmallCap 600 Health Care Specialized Services Index
11/06/00CryoLife's SynerGraft Tissue-Engineering Technology Featured At Cardiac Bioprostheses Symposium
10/17/00CryoLife, Inc. Reports Record Revenues and Improved Earnings For the Third Quarter and Nine Months Ended September 30, 2000
10/16/00CryoLife, Inc. Receives 'Ce Mark' Approval for Distribution of Synergraft(R) Tissue-Engineered Pulmonary Heart Valves in Europe
10/11/00CryoLife, Inc. Completes Sale of Ideas for Medicine Assets To Horizon Medical Products, Inc
09/06/00CryoLife, Inc. Reports Record Revenues For The First Two Months of the Third Quarter
08/11/00CryoLife, Inc. Advances Application of Its Tissue-Engineered Human Heart Valves
08/01/00CryoLife, Inc. Files Application With FDA for SynerGraft: World's First Tissue-Engineered Heart Valve
07/18/00CryoLife, Inc., Reports Record Revenues and Improved Earnings During the Second Quarter and First Half of 2000
07/12/00CryoLife-O'Brien Stentless Porcine Heart Valve Approved for Distribution in Canada
07/11/00CryoLife, Inc. Announces Inclusion in the Russell 2000 Index
06/29/00CryoLife, Inc. Purchases Acreage Designated For Future Growth and Expansion of Company Operations
06/26/00CryoLife's BioGlue Surgical Adhesive Presented At Thoracic Surgical Association Meeting
06/07/00CryoLife, Inc. Interview to be Broadcast on the Web
05/01/00CryoLife's BioGlue Surgical Adhesive Presented at Aortic Surgery Symposium
04/19/00CryoLife, Inc. Appoints David Ashley Lee Chief Financial Officer
04/18/00CryoLife, Inc. Reports Record Revenues And Record Earnings for First Quarter
04/13/00CryoLife, Inc. Expects Record Revenues And Improved Earnings for the First Quarter
03/30/00CryoLife, Inc. Receives Approval to Expand IDE Indications for BioGlue Under Conditions Specified by FDA
03/22/00CryoLife, Inc. Says Product Diversification Strategy Paying Off
03/01/00CryoLife, Inc. and Viragen Sign Collaborative Agreement for A Cancer Therapy Research Project
02/23/00CryoLife, Inc. Announces Implant of World's First Decellularized CryoValve-SG Human Heart Valve
02/22/00CryoLife, Inc. Receives Approval by 83 Hospitals for Use of BioGlue In Acute Thoracic Aortic Dissections
02/15/00CryoLife Announces Opening of European Headquarters
02/10/00CryoLife Breaks Ground On New High-tech Facility; CryoLife Doubles Its Corporate Campus Due to Demand For Company's Services And Products
02/08/00CryoLife, Inc. Reports Fourth Quarter and Full Year Results
02/02/00Cryolife's BioGlue Surgical Adhesive Featured At 36th Annual Meeting of the Society of Thoracic Surgeons
02/01/00Clinical Results of Synergraft Technology Presented at 36th Annual Meeting of Thoracic Surgeons
01/26/00CryoLife, Inc. Announces New CryoValve-SG for Transplant
01/24/00Clinical Results of Cryolife's Synergraft Technology Presented at 31st Cardiovascular Conference at Snowmass
01/19/00CryoLife Receives Approval to Market BioGlue Surgical Adhesive in Canada
01/06/00CryoLife Submits IDE Supplement to Expand Indications Of BioGlue in U.S.
01/04/00CryoLife Ships BioGlue Surgical Adhesive to U.S. Hospitals; HDE Approval Opens Door for Hospitals in the U.S. to Use BioGlue in Aortic Dissections
12/13/99FDA Grants CryoLife's BioGlue a Humanitarian Device Exemption for Limited Use in Aortic Dissections
10/19/99CryoLife, Inc. Continues to Report Record Quarterly Revenues
10/05/99CryoLife Continues to Make Advances With BioGlue; First Clinical Use of BioGlue in Japan; BG3000 Approved in France
10/04/99CryoLife Continues to See Positive Results in Patients Receiving SynerGraft Tissue-Engineered Heart Valves; Third and Fourth SynerGraft Heart Valve Implants Planned for this Week
09/16/99CryoLife Continues to Add Expertise to Company's Board of Directors
09/08/99CryoLife's BioGlue Surgical Adhesive Featured At European Association for Cardiothoracic Surgery
08/31/99CryoLife Announces First SynerGraft -R- Biologic Heart Valve Implants in Human Patients; Trans-species Transplant Performed Without Use of Immunosuppression
08/30/99CryoLife Expands Board; Adds Two New Board Members and A Wealth of Experience
08/16/99Cryolife, Inc. to Open European Headquarters
07/28/99CryoLife Seeks Canadian Marketing Approval for BioGlue Surgical Adhesive; BioGlue Now in Use in 33 Countries
07/26/99CryoLife Seeks Australian Marketing Approval for BioGlue Surgical Adhesive
07/20/99CryoLife, Inc. Reports Record Revenues for Second Quarter; Increasing Interest in New Products
07/07/99CryoLife Receives Approval for Clinical Testing of BioGlue in Japan
06/30/99CryoLife Stock Ranked Among the 100 Best Stocks to Own for Under $20
06/14/99CryoLife SynerGraft Technology Highlighted At World Symposium On Heart Valve Disease
06/10/99CryoLife Files Application With FDA For Humanitarian Device Exemption for BioGlue
06/09/99CryoLife Product Holds Great Promise for Dialysis Patients
05/17/99CryoLife's SynerGraft, First Effective ''Tissue Engineered'' Heart Valve Implant, Highlighted At International Symposium
05/06/99CryoLife Files for FDA Clearance to Distribute BioGlue Surgical Patch in U.S.
04/22/99CryoLife, Inc. Reports Record Revenues for 1999 First Quarter; Product and Service Diversification on Track
04/21/99CryoLife's BioGlue Surgical Adhesive Eliminates Need for Sutures in Experimental Coronary Bypass Surgery On Animals
04/19/99CryoLife, Inc. Introduces Heart Valve Warranty
04/05/99CryoLife, Inc. Announces First Shipment of BG3000 Pre-filled BioGlue Surgical Adhesive Delivery System
03/16/99CryoLife, Inc. Receives ''CE'' Mark for Distribution of BioGlue for Pulmonary Applications in the European Union
02/17/99CryoLife, Inc. Receives ''CE'' Mark For International Distribution Of New BioGlue Delivery System
02/09/99CryoLife, Inc. Will Add On-Line Tissue Availability Service To Its Worldwide Web Site
02/02/99CryoLife, Inc. Reports Revenues and Earnings for 1998
01/21/99CryoLife(R), Inc. Expands Its Line of Orthopaedic Tissues
10/14/98CryoLife(R), Inc. Reports Record Revenues And Earnings For Third Quarter And First Nine Months Of 1998
10/14/98CryoLife(R), Inc. Board Of Directors Authorize Purchase Of Its Common Stock
10/07/98CryoLife, Inc. Receives $2 Million Grant For Creation Of Bioengineered Heart Valves
10/01/98CryoLife(R), Inc. Announces Sale Of Its Ideas For Medicine(R), Inc. Product Line
09/30/98Horizon Medical Products, Inc. Announces Acquisition Of CryoLife, Inc. Subsidiary
09/30/98CryoLife, Inc. Begins Shipments Of Porcine Pulmonary Heart Valves To Europe
09/23/98CryoLife, Inc. Signs Agreement For Japanese Distribution Of BioGlue
09/18/98Horizon Medical Products, Inc. Signs Letter Of Intent To Acquire Cryolife, Inc. Subsidiary
09/18/98CryoLife, Inc. Signs Letter Of Intent For Ideas For Medicine, Inc. Product Line
07/29/98CryoLife, Inc. Announces Expansion Of Production Capacity For BioGlue And Porcine Heart Valves
07/21/98CryoLife, Inc. Reports Record Revenues And Earnings For Second Quarter And First Half Of 1998, Revenues For First Half Increase 35%
04/21/98CryoLife, Inc. Reports Record Revenues And Earnings For The First Quarter Of 1998